Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results - GlobeNewswire

Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results  GlobeNewswire

... -- NUZYRA™ (omadacycline) Launched in the United States for the Treatment of CABP and ABSSSI --. -- New England Journal of Medicine Publishes Results ...



Comments

Popular posts from this blog

Mpox - Vancouver